COLLEGE PARK, Md. (AP) - Federal health advisers say an
electronic heart implant should be approved for millions of new
heart-disease patients who currently aren't eligible for the
A Food and Drug Administration panel of cardiologists voted
unanimously in favor of Boston Scientific's heart-regulating device
to treat mild heart failure. Currently the device is approved for
moderate to severe heart failure.
The FDA is not required to follow the panel's advice, though it
A positive FDA decision would expand the market for the devices
by millions of patients.
The device combines a defibrillator, which shocks the heart to
correct irregular beats, with a resynchronization device to
coordinate the pumping action of the heart.
(Copyright 2010 by The Associated Press. All Rights Reserved.)